Cannabis Legalization is Driving an Increase in Related ER Visits
The legalization of both medical use and recreational use of cannabis in the United States has lead to an increase in both availability and potency.
Alcohol, Cannabis and Synergistic Risk
Although cannabis use is considered relatively benign, there is an increasing appreciation of the risks of cannabis over consumption and its burden on the healthcare system. However, there has been less discussion of the risks associated with the simultaneous consumption of alcohol and cannabis.
Cannabis Movers & Shakers: Creo, Harvest Health & Recreation, Glass House, Flora Growth, Anebulo, Cannformatics, Republic Brands
Creo Taps Graeme Kenny To Serve As New CRO
Cannabinoid ingredient company Creo has appointed Graeme Kenny as its new chief revenue officer.
With over two decades of experience working for Croda International Plc, Kenny will lead commercial rollout in the category of cannabinoid ingredients.
Anebulo Pharmaceuticals Announces Formation Of Scientific Advisory Board
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) (“Anebulo” or the “Company”), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid
Cannabis Over-Intoxication Results in Millions of Visits to the ER per Year
The burden on the healthcare system from cannabis use is often underappreciated, because many see the risks of smoking marijuana as low. However, there are a very large number of visits to the emergency room every year as a result of cannabis intoxication.
The Underappreciated Risk Of Pediatric Cannabis Overdose
There are major risks associated with the consumption of large amounts of cannabis by young children.
The Danger of Synthetic Cannabinoids
A problem of increasing social importance is the rise in the use of synthetic cannabis alternatives, commonly called K2 or Spice or a number of other brand names.
The Dark Side of Cannabis Legalization and one Biotech Company’s Solution
Photo credits: Tim Foster
As of July 2021, 18 states have legalized recreational marijuana while another 18 have legalized cannabis solely for medical purposes. Meanwhile, Florida, Connecticut and Hawaii all have introduced legislation supporting legalization.
Cannabinoid-Focused Anebulo Pharma Posts Q3 Earnings, On Schedule To Start Cannabis Overdose Clinical Trials
Cannabinoid-focused biotech company Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) released its third-quarter fiscal 2021 financial results on Tuesday with a net loss of $555,832 or $0.04 per share.
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-specific news flow dictated stock moves during the week.